In the grimdark future of the 41st millennium, there is only war, and you can fight your way through it, beginning with the ...

Charlotte Wood’s novel, a Booker Prize finalist, follows an atheist whose mysterious path led her to live among nuns in a ...

Long-awaited sequels, epic character comebacks, and lingering plot twists ready to be unleashed? Sounds like a cinephile’s ...

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook. Galapagos NV plans to split into two entities ...

We recently compiled a list of the 8 Best Humane Stocks to Invest in Now. In this article, we are going to take a look at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Both paperback and hardcover editions are up for preorder, both clocking in at 456 pages and including all entries in the ...

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine. However, Ben Hargreaves finds that the company’s ...

Wedge has co-written several books with author Casey Sherman, including “Boston Strong: A City’s Triumph Over Tragedy,” which ...